Physician profile
Mitkumar Patel
NPI 1912293812
$1,157.67
in general payments reported to CMS, 2019-2025
17 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.62 · 2020: $44.51 · 2021: $350 · 2022: $278 · 2023: $117 · 2024: $103 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $413.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $288.89 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $149.28 | 2019-2025 | |
| Heartflow, INC. | $119.67 | 2022 | |
| Shockwave Medical, INC | $103.07 | 2025 | |
| Amgen INC. | $80.26 | 2019-2023 | Repatha |
| Inspire Medical Systems, INC. | $75.81 | 2024-2025 | Inspire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.39 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.04 | 2022-2023 | Jardiance |
| Pfizer INC. | $45.42 | 2023-2024 | |
| Cvrx, INC. | $36.36 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $30.83 | 2021-2023 | Eliquis |
| Astrazeneca Pharmaceuticals Lp | $24.25 | 2024 | |
| Novo Nordisk INC | $23.25 | 2022 | |
| Boston Scientific Corporation | $21.43 | 2019 | |
| Merck Sharp & Dohme LLC | $20.69 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $17.73 | 2025 | Shingrix |
| Hydrofera LLC | $16.30 | 2025 | Hydrofera Blue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitkumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.